Raptor Pharmaceutical Corp. Company Profile (NASDAQ:RPTP)

Analyst Ratings

Consensus Ratings for Raptor Pharmaceutical Corp. (NASDAQ:RPTP) (?)
Ratings Breakdown: 4 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $11.00 (86.76% upside)

Analysts' Ratings History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Show:
DateFirmActionRatingPrice TargetActions
6/12/2016FBR & CoReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016WedbushReiterated RatingNeutral$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016Cowen and CompanyReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Leerink SwannReiterated RatingOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Oppenheimer Holdings Inc.Reiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2016JMP SecuritiesDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016Citigroup Inc.UpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/22/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016Q216($0.18)$28.52 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2016Q116($0.17)($0.17)$27.17 million$27.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415($0.19)($0.17)$26.08 million$24.67 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.18)($0.18)$24.25 million$25.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.21)($0.12)$21.40 million$23.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.25)($0.24)$19.10 million$20.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414($0.14)($0.25)$20.12 million$17.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.18)($0.04)$18.90 million$23.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.19)($0.15)$14.58 million$16.31 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q413($0.17)($0.20)$11.81 million$12.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2014Q313($0.18)($0.19)$10.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.30)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2013Q1 2013($0.27)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/9/2013Q1 2013($0.23)($0.26)$0.25 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/14/2012Q412($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.17)($0.15)($0.16)
Q2 20163($0.15)($0.14)($0.15)
Q3 20162($0.21)($0.15)($0.18)
Q4 20163($0.21)($0.14)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
9/9/2015Suzanne Louise BruhnDirectorSell18,258$12.47$227,677.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Raymond AndersonDirectorSell4,916$12.51$61,499.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2015Raymond AndersonDirectorSell8,084$12.52$101,211.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Llew KeltnerDirectorSell50,000$16.05$802,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Thomas E DaleyInsiderSell35,000$15.00$525,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Suzanne Louise BruhnDirectorSell30,000$13.45$403,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015Richard L FranklinDirectorSell10,000$9.61$96,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015Richard L FranklinDirectorSell10,000$10.37$103,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Christopher M StarrDirectorSell20,033$11.62$232,783.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Richard L FranklinDirectorSell10,000$9.18$91,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Christopher M StarrDirectorSell30,000$9.52$285,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Richard L FranklinDirectorSell7,109$9.20$65,402.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2015Christopher M StarrDirectorSell30,000$9.45$283,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2015Christopher M StarrDirectorSell30,000$9.73$291,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Raymond AndersonDirectorSell10,000$10.58$105,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Christopher M StarrCEOSell30,000$9.00$270,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Christopher M StarrCEOSell30,000$8.15$244,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Christopher M StarrCEOSell30,000$9.97$299,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2014Christopher M StarrCEOSell30,000$10.25$307,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2014Christopher M StarrCEOSell30,000$10.21$306,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Christopher M StarrCEOSell32,896$10.60$348,697.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Raymond AndersonDirectorSell10,000$10.81$108,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Erich SagerDirectorSell10,000$11.01$110,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Llew KeltnerDirectorSell10,000$11.21$112,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Georgia ErbezCFOBuy16,100$7.90$127,190.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2014Vijay SamantDirectorSell5,000$8.59$42,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Christopher StarrCEOSell19,316$10.79$208,419.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Timothy WalbertDirectorSell5,520$15.06$83,131.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Thomas DaleyInsiderSell15,000$14.17$212,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Llew KeltnerDirectorSell10,000$13.25$132,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Richard FranklinDirectorSell10,715$13.12$140,580.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013Vijay SamantDirectorSell5,000$13.86$69,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2013Timothy WalbertDirectorSell5,521$12.44$68,681.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2013Richard FranklinDirectorSell10,715$14.88$159,439.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013Christopher M StarrCEOSell25,000$13.77$344,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2013Suzanne Louise BruhnDirectorSell2,760$13.58$37,480.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2013Vijay SamantDirectorSell5,000$14.76$73,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Christopher StarrCEOSell25,000$14.21$355,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Erich SagerDirectorSell17,000$14.21$241,570.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Suzanne Louise BruhnDirectorSell2,760$14.07$38,833.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Richard L FranklinDirectorSell10,715$14.24$152,581.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Thomas E DaleyInsiderSell25,000$14.28$357,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Georgia ErbezCFOSell7,400$13.42$99,308.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Erich SagerDirectorSell11,279$5.00$56,395.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
DateHeadline
07/29/16 06:22 PMCan Shares Of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Hit $11? - Investor Newswire
07/28/16 06:58 AMRaptor Pharmaceutical to Hold Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4, 2016, at 4:30 p.m. EDT - [at noodls] - NOVATO, Calif., July 28, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release second quarter 2016 financial results on Thursday, August 4, 2016, ...
07/23/16 05:40 PMIs $11 Price Target Attainable For Raptor Pharmaceutical Corp. (NASDAQ:RPTP)? - Investor Newswire
07/22/16 09:07 AMRaptor Pharmaceutical Corp. on Focus After Raising In Today's Session - Consumer Eagle
07/22/16 09:07 AMRaptor Pharmaceutical Corporation (NASDAQ:RPTP) Shorted Shares Increased By 5.98% - Consumer Eagle
07/21/16 09:02 AMRaptor Pharmaceutical Corp. (NASDAQ:RPTP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 09:02 AMRaptor Pharmaceuticals Corp. Price Volatility Hits An Elevated Level - CML News
07/17/16 10:16 AMRaptor Pharmaceutical Corp. (RPTP) Broker Price Targets For The Coming Week - Fiscal Standard
07/16/16 09:26 AMHow Analysts Feel About Raptor Pharmaceutical Corp. (NASDAQ:RPTP)? - Consumer Eagle
07/16/16 09:26 AMStrong Sell Calls For Raptor Pharmaceutical Corp. (NASDAQ:RPTP) At 0 - Investor Newswire
07/16/16 09:26 AMBroker Outlook For Raptor Pharmaceutical Corp. (RPTP) - Fiscal Standard
07/12/16 10:34 AMOption Market: Raptor Pharmaceuticals Corp. Risk Hits An Extreme High - CML News
07/12/16 10:34 AMStock Volatility Focus for: Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) - Engelwood Daily
07/08/16 09:03 AMRaptor Pharmaceuticals Corp. Upside Stock Momentum at Extreme Strength - CML News
07/08/16 09:03 AMRaptor Pharmaceutical Corporation (NASDAQ:RPTP) Shorted Shares Increased By 0.42% - Engelwood Daily
07/07/16 03:41 PMRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Termination of a Material Definitive Agreement -
07/07/16 08:59 AMNew Broker Ratings For Raptor Pharmaceutical Corp. (RPTP) - FTSE News
07/06/16 06:34 PMShare Performance Recap for: Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) - Press Telegraph
07/06/16 06:34 PMCan Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Improve on the Earnings Front? - Engelwood Daily
07/02/16 05:44 PMAre Analysts Bearish Raptor Pharmaceutical Corp. (NASDAQ:RPTP) After Last Week? - Press Telegraph
06/29/16 08:57 AMCovering the Bases on Raptor Pharmaceutical Corp. (NASDAQ:RPTP): Where is the Stock Going? - Press Telegraph
06/29/16 08:57 AMRaptor Pharmaceutical Corp. (RPTP) Updated Price Targets - FTSE News
06/26/16 05:12 PMStrong Sell Calls Recommendations For Raptor Pharmaceutical Corp. (NASDAQ:RPTP) At 0 - Investor Newswire
06/26/16 05:12 PMRaptor Pharmaceutical Corp. (RPTP) Jumps 6.43% on June 23 - Equities.com
06/23/16 01:29 PMRaptor Pharmaceutical Corp. – Value Analysis (NASDAQ:RPTP) : June 23, 2016 -
06/23/16 08:51 AMRaptor Pharmaceutical Corp. (RPTP) Drops 5.74% on June 21 - Equities.com
06/22/16 06:09 PMRaptor Pharmaceutical (NASDAQ:RPTP) Analyst Rating Consensus - TheFounders Daily
06/22/16 06:09 PMRaptor Pharmaceuticals Corp. (NasdaqGM:RPTP) Stock Momentum at Critical Inflection Point - CML News
06/22/16 07:18 AMRaptor Pharmaceutical Corp. breached its 50 day moving average in a Bearish Manner : RPTP-US : June 22, 2016 -
06/20/16 07:45 AMThis Weeks Broker Views For Raptor Pharmaceutical Corp. (RPTP) - Fiscal Standard
06/19/16 09:59 AMStrong Buy Calls Count For Raptor Pharmaceutical Corp. (NASDAQ:RPTP) At 3 - Investor Newswire
06/14/16 06:49 AMRaptor Pharmaceutical to Participate in the 2016 JMP Life Sciences Conference - [at noodls] - NOVATO, Calif., June 14, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will participate in the following investor conference: Julie Anne Smith, President and ...
06/11/16 09:05 AMRaptor Pharma Reports Data from Phase 3 Study of QUINSAIR
06/11/16 09:05 AMNovato’s Raptor Pharmaceuticals reports fewer lung issues in cystic fibrosis patients with its drug
06/10/16 07:09 AMRaptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR™ at the 39th European Cystic Fibrosis Conference - [at noodls] - NOVATO, Calif., June 10, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company developing and commercializing transformative treatments for rare diseases, today ...
06/10/16 07:06 AM8:06 am Raptor Pharma announces new data analyses of its Phase 3 clinical study (MPEX-209) comparing QUINSAIRTM to inhaled tobramycin solution in patients with cystic fibrosis at the European Cystic Fibrosis Conference -
06/08/16 06:42 PMRAPTOR PHARMACEUTICALS CORP. (NASDAQ:RPTP) Financial Condition Compared to S&P 500 - CML News
06/08/16 09:12 AMAnother Look At Raptor Pharmaceutical Corp. - Seeking Alpha
06/07/16 03:28 PMRaptor Pharmaceutical to Present Data on QUINSAIR™ at European Cystic Fibrosis Conference - [at noodls] - NOVATO, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company developing and commercializing transformative treatments for rare diseases, today ...
06/06/16 06:08 PMAnother Look At Raptor Pharmaceuticals - Seeking Alpha
05/31/16 06:31 PMShare Rating Focus on Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - HNN - Share Rating Focus on Raptor Pharmaceutical Corp. (NASDAQ:RPTP)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 2 on shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP). Covering analysts will ...and more »
05/31/16 06:31 PMNews Sentiment For Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - Investor Newswire - News Sentiment For Raptor Pharmaceutical Corp. (NASDAQ:RPTP)Investor NewswireRaptor Pharmaceutical Corp. (NASDAQ:RPTP) Average broker stands at 2 while it was 2 three months ago. The quarterly report of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) can be made public close to 2016-08-04. It is estimated by the recent update ...and more »
05/31/16 09:44 AMStock's Move to Focus: Raptor Pharmaceutical Corp. (NASDAQ:RPTP) , Becton, Dickinson and Company (NYSE:BDX) - Street Updates - Stock's Move to Focus: Raptor Pharmaceutical Corp. (NASDAQ:RPTP) , Becton, Dickinson and Company (NYSE:BDX)Street UpdatesIn the liquidity ratio analysis; Raptor Pharmaceuticals Corp.'s (RPTP) debt to equity ratio was 1.33 while current ratio was 4.20. The company has the institutional ownership of 63.60% while the Beta factor was 1.25. The stock's RSI amounts to 62.49 ...and more »
05/29/16 11:31 PMRaptor Pharmaceutical Corporation (NASDAQ:RPTP) Shorted Shares Increased By 5.17% - HNN - Raptor Pharmaceutical Corporation (NASDAQ:RPTP) Shorted Shares Increased By 5.17%HNNThe stock of Raptor Pharmaceutical Corporation (NASDAQ:RPTP) registered an increase of 5.17% in short interest. RPTP's total short interest was 6.42 million shares in May as published by FINRA. Its up 5.17% from 6.10M shares, reported previously.
05/24/16 10:29 AMRaptor Pharmaceutical Corp. Just Recorded A Sigfniciant Decline - Wall Street Hints and News - Raptor Pharmaceutical Corp. Just Recorded A Sigfniciant DeclineWall Street Hints and NewsThe stock of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) is a huge mover today! The stock decreased 2.69% or $0.14 during the last trading session, hitting $5.06. About 384,322 shares traded hands. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) has ...
05/22/16 05:57 PMNext Weeks Broker Price Targets For Raptor Pharmaceutical Corp. (RPTP) - Share Trading News - Next Weeks Broker Price Targets For Raptor Pharmaceutical Corp. (RPTP)Share Trading News04/07/2016 – Raptor Pharmaceutical Corp. was upgraded to “market outperform” by analysts at JMP Securities. They now have a USD 9 price target on the stock. 02/26/2016 – Raptor Pharmaceutical Corp. had its “outperform” rating reiterated by analysts at ...and more »
05/20/16 10:21 AMNotable Thursday Option Activity: RPTP, WBC, TTWO - Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Raptor Pharmaceuticals Corp. (Symbol: RPTP), where a total of 3,168 contracts have traded so far, representing approximately 316,800 underlying shares.
05/19/16 06:32 PMRevenue Update on Raptor Pharmaceutical Corp.(NASDAQ:RPTP) - Trade Calls - Revenue Update on Raptor Pharmaceutical Corp.(NASDAQ:RPTP)Trade CallsRaptor Pharmaceutical Corp.(NASDAQ:RPTP) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 5, 2016. Company reported revenue of $27.47M. Analysts estimated a revenue of $27.17M. Earnings ...Raptor Pharmaceutical Corp. (NASDAQ:RPTP): Stock Rating and Earnings ReviewFranklin IndependentRaptor Pharmaceutical Corp. (NASDAQ:RPTP) Hovering Around $4.78Equities FocusAnalyst Recommendations On Raptor Pharmaceutical Corp. (NASDAQ:RPTP)News Tribuneall 5 news articles »
05/19/16 10:01 AMTraders Checklist Stocks: Arrowhead Research Corporation (NASDAQ:ARWR) , Raptor Pharmaceutical Corp ... - Street Updates - Traders Checklist Stocks: Arrowhead Research Corporation (NASDAQ:ARWR) , Raptor Pharmaceutical Corp ...Street UpdatesRaptor Pharmaceutical Corp. (NASDAQ:RPTP) moved in green zone with rise of +0.06 points or +1.27% to $4.78. The company has a market worth of $407.76M.Total 502.39 thousand shares were exchanged in last trading session as opposed to average ...and more »
05/17/16 07:19 AMRaptor Pharmaceutical Corp. breached its 50 day moving average in a Bullish Manner : RPTP-US : May 17, 2016 -

Social

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. logoRaptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RPTP
  • CUSIP: 75382F10
Key Metrics:
  • Previous Close: $5.89
  • 50 Day Moving Average: $5.62
  • 200 Day Moving Average: $4.76
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $502.45M
  • Beta: 1.32
  • Current Year EPS Consensus Estimate: $-0.99 EPS
  • Next Year EPS Consensus Estimate: $-0.41 EPS
Additional Links:
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Chart for Saturday, July, 30, 2016